当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:736.30亿  总市值:736.30亿
流通股本:12.65亿   总股本:12.65亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,090,752,777.2574,456,759.023,318,765,321.942,603,435,943.52
  收到的税费返还3,068.483,068.4821,923,520.7915,517,901.31
  收到其他与经营活动有关的现金78,865,735.8254,063,460.64329,904,788.73263,304,643.77
  经营活动现金流入小计1,169,621,581.5628,523,288.143,670,593,631.462,882,258,488.6
  购买商品、接受劳务支付的现金263,620,598.96176,433,601.75622,620,315.28549,740,535.96
  支付给职工以及为职工支付的现金574,836,717.51344,074,013.121,032,462,819.19792,079,897
  支付的各项税费80,202,387.8841,000,836.75136,080,057.5895,562,947.69
  支付其他与经营活动有关的现金317,515,282.71152,987,767.181,524,348,792.721,247,079,848.68
  经营活动现金流出小计1,236,174,987.06714,496,218.83,315,511,984.772,684,463,229.33
  经营活动产生的现金流量净额-66,553,405.56-85,972,930.66355,081,646.69197,795,259.27
二、投资活动产生的现金流量:
  收回投资收到的现金2,218,505,7601,678,259,0805,932,026,208.333,859,025,208.33
  取得投资收益收到的现金49,474,203.317,742,951.9143,174,782.7676,010,132.7
  处置固定资产、无形资产和其他长期资产收回的现金净额44,768.8543,756.4616,055,582.5515,979,917.11
  收到的其他与投资活动有关的现金--25,400,359.52-
  投资活动现金流入小计2,268,024,732.151,696,045,788.366,116,656,933.163,951,015,258.14
  购建固定资产、无形资产和其他长期资产支付的现金432,022,484.44155,283,188.38887,349,661.68704,898,313.33
  投资支付的现金--6,726,681,360-
  支付其他与投资活动有关的现金2,335,361,2001,947,000,0005,985,111.684,088,095,000
  投资活动现金流出小计2,767,383,684.442,102,283,188.387,620,016,133.364,792,993,313.33
  投资活动产生的现金流量净额-499,358,952.29-406,237,400.02-1,503,359,200.2-841,978,055.19
三、筹资活动产生的现金流量:
  吸收投资收到的现金--78,213,621.53-
  取得借款收到的现金119,383,754.94-231,236,626.5552,210,000
  收到其他与筹资活动有关的现金1,214,782.56812,082.56-101,112,146.85
  筹资活动现金流入小计120,598,537.5812,082.56309,450,248.08153,322,146.85
  偿还债务支付的现金160,733,219.517,086,760252,388,246.49111,496,140
  分配股利、利润或偿付利息支付的现金1,082,833.08581,430.98410,941,371.27409,192,572.67
  其中:子公司支付给少数股东的股利、利润--760,500760,500
  支付其他与筹资活动有关的现金5,565,057.081,895,201.35258,864,052.23252,282,074.11
  筹资活动现金流出小计167,381,109.6619,563,392.33922,193,669.99772,970,786.78
  筹资活动产生的现金流量净额-46,782,572.16-18,751,309.77-612,743,421.91-619,648,639.93
四、汇率变动对现金及现金等价物的影响-891,741.35-233,920.664,384,996.85-3,469,849.79
五、现金及现金等价物净增加额-613,586,671.36-511,195,561.11-1,756,635,978.57-1,267,301,285.64
  加:期初现金及现金等价物余额2,027,005,826.52,027,005,826.53,783,641,805.073,783,641,805.07
  期末现金及现金等价物余额1,413,419,155.141,515,810,265.392,027,005,826.52,516,340,519.43
补充资料:
  净利润-145,492,229.78-109,094,522.37-
  资产减值准备23,426,159.84-103,626,312.79-
  固定资产和投资性房地产折旧126,633,472.93-229,127,550.66-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧126,633,472.93-229,127,550.66-
  无形资产摊销19,133,905.37-31,581,210.67-
  长期待摊费用摊销10,394,548.6-17,590,376.96-
  处置固定资产、无形资产和其他长期资产的损失146,644.6--7,923,472.52-
  固定资产报废损失1,117,276.03-533,053.64-
  公允价值变动损失-17,591,273.78--36,707,335.76-
  财务费用3,408,049.43--25,056,750.39-
  投资损失-44,357,628.65--109,636,079.11-
  递延所得税-8,191,106.5--85,378,260.2-
  其中:递延所得税资产减少-8,191,106.5--85,378,260.2-
  存货的减少-110,937,022.61--58,184,275.09-
  经营性应收项目的减少140,006,200.46-940,331,796.27-
  经营性应付项目的增加-142,749,151.44--805,750,311.64-
  其他---5,280,060.19-
  不涉及现金收支的投资和筹资活动金额其他项目--132,741,337.08-
  现金的期末余额1,413,419,155.14-2,027,005,826.5-
  减:现金的期初余额2,027,005,826.5-3,783,641,805.07-
  现金及现金等价物的净增加额-613,586,671.36--1,756,635,978.57-
公告日期2025-08-212025-04-252025-04-122024-10-25
审计意见(境内)标准无保留意见
TOP↑